Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 22 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 10588984

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  2. US 10583173

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  3. US 10584161

    Monoclonal antibodies specific for heartland virus and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  4. US 10576059

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  5. US 10577349

    Quinolinones as inhibitors of translation initiation complex

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  6. US 10577368

    A3 adenosine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  7. US 10570172

    Self-assembling amphiphilic peptides

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  8. US 10570214

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  9. US 10561729

    Near-IR light-cleavable conjugates and conjugate precursors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  10. US 10561666

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  11. US 10561673

    Dendrimer based nanodevices for therapeutic and imaging purposes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  12. US 10562952

    Anti-CD276 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  13. US 10561724

    Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  14. US 10562960

    Neutralizing antibodies to gp120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  15. US 10561722

    Methods and compositions for enhancing immune responses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  16. US 10562843

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  17. US 10561721

    Methods and compositions for inducing protective immunity against filovirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  18. US 10556916

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  19. US 10556001

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  20. US 10556940

    T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  21. US 10555942

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  22. US 10550164

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  23. US 10548987

    Antibody-drug conjugates for targeting CD56-positive tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  24. US 10548970

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted